Investigational Product Discontinuation Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238

Investigational Product Discontinuation - Rosiglitazone
Description

Investigational Product Discontinuation - Rosiglitazone

Alias
UMLS CUI-1
C0013230
UMLS CUI-2
C0457454
Was the investigational product stopped permanently before the end of the scheduled treatment period?
Description

Investigational Product

Data type

boolean

Alias
UMLS CUI [1]
C0304229
If Yes, check the primary reason the investigational product was stopped:
Description

Discontinuation

Data type

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
Specify other:
Description

Specification other

Data type

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C2348235

Similar models

Investigational Product Discontinuation Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease NCT00381238

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Investigational Product Discontinuation - Rosiglitazone
C0013230 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
Investigational Product
Item
Was the investigational product stopped permanently before the end of the scheduled treatment period?
boolean
C0304229 (UMLS CUI [1])
Item
If Yes, check the primary reason the investigational product was stopped:
integer
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Code List
If Yes, check the primary reason the investigational product was stopped:
CL Item
Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Disease progression (7)
CL Item
Other, specify (8)
Specification other
Item
Specify other:
text
C0304229 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])